C. R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. The company offers vascular products, such as percutaneous transluminal angioplasty catheters, chronic total occlusions catheters, guidewires, fabrics, meshes, introducers, and accessories; peripheral vascular stents, covered stents, and vascular grafts; vena cava filters; biopsy devices; electrophysiology products; and drug coated balloon devices to treat peripheral vascular disease and heart arrhythmias. Its urology products comprise Foley catheters to reduce the rate of urinary tract infections; surgical slings to treat stress urinary incontinence; fecal incontinence products; natural and synthetic devices to treat pelvic floor and vaginal prolapse; brachytherapy services, devices, and radioactive seeds to treat prostate cancer; intermittent urinary drainage catheters, and urine monitoring and collection systems; ureteral stents; specialty devices for stone removal; catheter stabilization devices; and products for therapeutic hypothermia. The company also provides oncology products, such as specialty vascular access catheters and ports, vascular access ultrasound devices, dialysis access catheters, and enteral feeding devices to treat and manage various cancers, and other diseases and disorders. Its surgical specialty products include soft tissue repair products, such as hernia repair grafts and hernia fixation devices; surgical sealants for intraoperative sealing of air leaks in thoracic surgery; and other products, such as irrigation, wound drainage, and original equipment manufacturers’ products. The company sells its products to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities directly, as well as through hospital/surgical supply and other medical specialty distributors. C. R. Bard, Inc. was founded in 1907 and is headquartered in Murray Hill, New Jersey.

Key Statistics